"The future is already here -it's just not very evenly distributed."
THE IMPLEMENTATION GAP
The continuing challenge of RHD is not one of understanding how to prevent and treat it but rather a failure of widespread implementation of effective prevention and treatment [6] . Imagine a future scenario, a world in which all group A streptococcal pharyngitis is readily identified at the point of care, definitive acute treatment is prescribed, the effective medication is readily available and affordable in all health care settings, and the prescribed long-term secondary prophylaxis is widely acceptable and affordable from the patient's perspective. That future is already here, but as William Gibson so eloquently put it, "it's just not very evenly distributed." In the continental United States for example, annual incidence of acute rheumatic fever (ARF) declined in the latter part of the 20th century to approximately 0.04 to 0.06 cases per 1,000 children, leading to the discontinuation of ARF as a nationally reportable condition [7] . However, as reported by Beaudoin et al. [8] , the incidence of ARF in Samoan persons living in Hawaii and residents of American Samoa, a United States territory in the South Pacific, remains significantly high. In fact, the RHD point prevalence of 3.2 per 1,000 children in August 2013 was nearly 10 times that estimated for high-income industrialized countries [8] . Similar disparities have been noted in indigenous peoples elsewhere in the United States, Canada, Australia, and New Zealand [9] [10] [11] . The drivers of these disparities are complex and include social, environmental, genetic, behavioral, and lifestyle factors. Importantly, these disparities also reflect an implementation gap-a gap that could be addressed with rigorous research that advances effective strategies. The good news is that we have evidence of strategies that have worked to reduce the burden of ARF and RHD.
EVIDENCE OF SUCCESSFUL IMPLEMENTATION STRATEGIES
More than 3 decades ago, the World Health Organization, in close collaboration with the International Society and Federation of Cardiology (now the World Heart Federation) initiated a rheumatic fever/RHD program that engaged 16 countries including Mali, Zambia, and Zimbabwe (in Africa); Bolivia, El Salvador, and Jamaica (in the Americas); Egypt, Iraq, Pakistan, and Sudan (in the Eastern Mediterranean); India, Sri Lanka, and Thailand (in South-East Asia); and China, the Philippines, and Tonga (in the Western Pacific) [12] . The program identified and registered 3,135 cases of rheumatic fever/RHD and successfully provided 63.2% coverage in terms of completion of secondary prophylaxis [12] . The occurrence of adverse events (0.3%) and ARF recurrence (0.4%) was low. The program also trained 24,398 health personnel and teachers and used multiple mass media channels (radio, television, posters, pamphlets, and brochures) to advance health promotion and education for the prevention and control of rheumatic fever and RHD.
Among Indigenous communities of Aboriginal Australians, Ralph et al. [13] recently demonstrated that the development and execution of a continuous quality improvement strategy for implementation of national bestpractice management guidelines at the primary health care level can successfully improve the management of ARF and RHD. Their systems approach and participatory action
